In 2025, Fisher & Paykel Healthcare completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Fisher & Paykel Healthcare has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Fisher & Paykel Healthcare’s data sources below and access millions more through our Disclosure Search.
In 2025, the total operational greenhouse gas (GHG) emissions of Fisher & Paykel Healthcare amounted to 15,527 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Fisher & Paykel Healthcare decreased by 4.78%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
In 2025, the total Scope 1 emissions of Fisher & Paykel Healthcare were 2,295 metric tons of CO₂ equivalent (tCO₂e). a
Since 2020, Fisher & Paykel Healthcare's Scope 1 emissions have increased by 19.91%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2024), Fisher & Paykel Healthcare's Scope 1 emissions increased by 14.01%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
In 2025, Fisher & Paykel Healthcare reported Scope 2 greenhouse gas (GHG) emissions of 12,406 tCO₂e using the market-based method and 13,232 tCO₂e using the location-based method. a
Compared to the previous year (2024), Fisher & Paykel Healthcare's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Fisher & Paykel Healthcare 's emissions have plateaued with no significant change in its energy consumption footprint. a
In 2025, Fisher & Paykel Healthcare reported its Scope 2 emissions using the market-based method and using the location-based method. a
In 2025, Fisher & Paykel Healthcare reported 266,044 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2025 disclosure of Fisher & Paykel Healthcare includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
In 2025, Fisher & Paykel Healthcare reported total Scope 3 emissions of 266,044 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 54.64% of these emissions originated from upstream activities such as purchased goods and capital goods, while 45.36% came from downstream activities like product use, distribution, and end-of-life treatment. a
Since 2020, Fisher & Paykel Healthcare's Scope 3 emissions have decreased by 59.07%, reflecting a declining long-term trend in Scope 3 emissions over time. a b
Compared to the previous year (2024), Fisher & Paykel Healthcare's Scope 3 emissions increased by 10.2%, suggesting that the company faced challenges in reducing emissions across its value chain. a
In 2025, Fisher & Paykel Healthcare reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This reflects a high level of granularity and transparency in the company's emissions reporting.
In 2025, the largest contributors to Fisher & Paykel Healthcare's Scope 3 emissions were: a
In 2025, Fisher & Paykel Healthcare reported Scope 1 greenhouse gas (GHG) emissions of 2,295 tCO₂e and total revenues of USD 727 millions. This translates into an emissions intensity of 3.16 tCO₂e per millions USD. a
In 2025, Fisher & Paykel Healthcare reported a Scope 1 emissions intensity of 3.16 tCO₂e per millions USD. Compared to the peer group median of 5.33 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
In 2025, Fisher & Paykel Healthcare ranked 7 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Fisher & Paykel Healthcare is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a
In 2025, Fisher & Paykel Healthcare reported a total carbon footprint of 281,571 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 9.25% increase compared to 2024, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to Fisher & Paykel Healthcare's total carbon footprint was Scope 3 emissions, accounting for 94.49% of the company's total carbon footprint, followed by Scope 2 emissions at 4.7%. a